# EDGAR Filing Document

**Accession Number:** 0001064642
**File Stem:** 0001752724-23-046888
**Filing Date:** 2023-2
**Character Count:** 19196
**Document Hash:** e89abe67722cb1f86be7440994910f84
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001752724-23-046888.hdr.sgml**: 20230228

**ACCESSION NUMBER**: 0001752724-23-046888

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230228

**DATE AS OF CHANGE**: 20230228

**PERIOD START**: 20230630

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SPDR SERIES TRUST
- **CENTRAL INDEX KEY:** 0001064642
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** MA

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-08839
- **FILM NUMBER:** 23683460

**BUSINESS ADDRESS:**
- **STREET 1:** ONE LINCOLN STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02111
- **BUSINESS PHONE:** 617-664-1465

**MAIL ADDRESS:**
- **STREET 1:** ONE LINCOLN STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02111

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** STREETTRACKS SERIES TRUST
- **DATE OF NAME CHANGE:** 20000925

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** INDEX EXCHANGE LISTED SECURITIES TRUST
- **DATE OF NAME CHANGE:** 19980622

## Series and Classes Contracts Data

### SPDR(R) S&P(R) Pharmaceuticals ETF (Series ID: S000012321)

| Class ID   | Class Name                         | Ticker Symbol   |
|:---|:---|:---|
| C000033537 | SPDR(R) S&P(R) Pharmaceuticals ETF | XPH             |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** SPDR SERIES TRUST

- **b. Investment Company Act file number:** 811-08839

- **c. CIK number of Registrant:** 0001064642

- **d. LEI of Registrant:** 5493004JVD6CQEEJSS37

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** One Iron Street

  - **City:** Boston

  - **State:** MA

  - **Foreign country:** US

  - **Zip / Postal Code:** 02210

  - **Telephone number:** 617-664-8594

**Item A.2. Information about the Series.**

- **a. Name of Series:** SPDR(R) S&P(R) Pharmaceuticals ETF

- **b. EDGAR series identifier (if any):** S000012321

- **c. LEI of Series:** 549300YVZ2R8N1KQH698

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2023-06-30

- **b. Date as of which information is reported:** 2022-12-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $223284901.19

**Total Liabilities:** $18369053.85

**Net Assets:** $204915847.34

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000033537 | 5.38%                | 1.61%                | -4.15%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $268060.00               | $10524073.93                               |
| Month 2  | $1572772.96              | $1802053.78                                |
| Month 3  | $-15181520.56            | $6168941.31                                |

### Schedule of Portfolio Investments

| Name                             | Title                                                                       | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Ligand Pharmaceuticals Inc       | Ligand Pharmaceuticals Inc                                                  | CUSIP: 53220K504<br>LEI: 5493008K7TB0IKP37H79 | Long             | EC               | CORP              | US        |     43547 | NS      | $2908939.60   | 1.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Pliant Therapeutics Inc          | Pliant Therapeutics Inc                                                     | CUSIP: 729139105<br>LEI: 5493002Q5LITR7VHZH02 | Long             | EC               | CORP              | US        |     99798 | NS      | $1929095.34   | 0.94%             |  |  |  | No            |                  1 | On Loan: No      |
| Revance Therapeutics Inc         | Revance Therapeutics Inc                                                    | CUSIP: 761330109<br>LEI: 549300N33TFDZHS81H11 | Long             | EC               | CORP              | US        |    376810 | NS      | $6955912.60   | 3.39%             |  |  |  | No            |                  1 | On Loan: No      |
| Viatris Inc                      | Viatris Inc                                                                 | CUSIP: 92556V106<br>LEI: 254900ZZTSW7NL773X71 | Long             | EC               | CORP              | US        |    823109 | NS      | $9161203.17   | 4.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson                | Johnson & Johnson                                                           | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |     50491 | NS      | $8919235.15   | 4.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Prestige Consumer Healthcare Inc | Prestige Consumer Healthcare Inc                                            | CUSIP: 74112D101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     47414 | NS      | $2968116.40   | 1.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Pacira BioSciences Inc           | Pacira BioSciences Inc                                                      | CUSIP: 695127100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     96982 | NS      | $3744475.02   | 1.83%             |  |  |  | No            |                  1 | On Loan: No      |
| Aclaris Therapeutics Inc         | Aclaris Therapeutics Inc                                                    | CUSIP: 00461U105<br>LEI: 5493000B2LQ9QTW1DF52 | Long             | EC               | CORP              | US        |     72261 | NS      | $1138110.75   | 0.56%             |  |  |  | No            |                  1 | On Loan: —       |
| Nektar Therapeutics              | Nektar Therapeutics                                                         | CUSIP: 640268108<br>LEI: 5299005I24806IOIYE03 | Long             | EC               | CORP              | US        |    417611 | NS      | $943800.86    | 0.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Theravance Biopharma Inc         | Theravance Biopharma Inc                                                    | CUSIP: 000000000<br>LEI: 5493007VTSXP4Z6MIW52 | Long             | EC               | CORP              | KY        |    146047 | NS      | $1638647.34   | 0.80%             |  |  |  | No            |                  1 | On Loan: —       |
| Collegium Pharmaceutical Inc     | Collegium Pharmaceutical Inc                                                | CUSIP: 19459J104<br>LEI: 54930049FXZMTLW8D496 | Long             | EC               | CORP              | US        |     39991 | NS      | $927791.20    | 0.45%             |  |  |  | No            |                  1 | On Loan: No      |
| Supernus Pharmaceuticals Inc     | Supernus Pharmaceuticals Inc                                                | CUSIP: 868459108<br>LEI: 549300GRM36VBKISYJ58 | Long             | EC               | CORP              | US        |     79431 | NS      | $2833303.77   | 1.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Esperion Therapeutics Inc        | Esperion Therapeutics Inc                                                   | CUSIP: 29664W105<br>LEI: 549300OFU56UKEWVUS92 | Long             | EC               | CORP              | US        |    326228 | NS      | $2032400.44   | 0.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Zoetis Inc                       | Zoetis Inc                                                                  | CUSIP: 98978V103<br>LEI: 549300HD9Q1LOC9KLJ48 | Long             | EC               | CORP              | US        |     57846 | NS      | $8477331.30   | 4.14%             |  |  |  | No            |                  1 | On Loan: No      |
| ANI Pharmaceuticals Inc          | ANI Pharmaceuticals Inc                                                     | CUSIP: 00182C103<br>LEI: 5493000T6CXTND40YH31 | Long             | EC               | CORP              | US        |     11868 | NS      | $477449.64    | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Amphastar Pharmaceuticals Inc    | Amphastar Pharmaceuticals Inc                                               | CUSIP: 03209R103<br>LEI: 54930055TH0ZLSAQMJ38 | Long             | EC               | CORP              | US        |     51624 | NS      | $1446504.48   | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Cassava Sciences Inc             | Cassava Sciences Inc                                                        | CUSIP: 14817C107<br>LEI: 529900XA0UG5JXABYF08 | Long             | EC               | CORP              | US        |    229102 | NS      | $6767673.08   | 3.30%             |  |  |  | No            |                  1 | On Loan: —       |
| Provention Bio Inc               | Provention Bio Inc                                                          | CUSIP: 74374N102<br>LEI: 5493003LM26XAVJKLD34 | Long             | EC               | CORP              | US        |    189653 | NS      | $2004632.21   | 0.98%             |  |  |  | No            |                  1 | On Loan: —       |
| Cara Therapeutics Inc            | Cara Therapeutics Inc                                                       | CUSIP: 140755109<br>LEI: 549300COVOY41P0GZ881 | Long             | EC               | CORP              | US        |     64606 | NS      | $693868.44    | 0.34%             |  |  |  | No            |                  1 | On Loan: —       |
| Axsome Therapeutics Inc          | Axsome Therapeutics Inc                                                     | CUSIP: 05464T104<br>LEI: 549300EXGR0XLRJEIB95 | Long             | EC               | CORP              | US        |    118530 | NS      | $9142218.90   | 4.46%             |  |  |  | No            |                  1 | On Loan: —       |
| Intra-Cellular Therapies Inc     | Intra-Cellular Therapies Inc                                                | CUSIP: 46116X101<br>LEI: 5299002U2KGF193IJA20 | Long             | EC               | CORP              | US        |    133796 | NS      | $7080484.32   | 3.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Perrigo Co PLC                   | Perrigo Co PLC                                                              | CUSIP: 000000000<br>LEI: 549300IFOQS6R1QLY196 | Long             | EC               | CORP              | IE        |    281239 | NS      | $9587437.51   | 4.68%             |  |  |  | No            |                  1 | On Loan: No      |
| Reata Pharmaceuticals Inc        | Reata Pharmaceuticals Inc                                                   | CUSIP: 75615P103<br>LEI: 5299005F094GH9QDDD80 | Long             | EC               | CORP              | US        |    131189 | NS      | $4983870.11   | 2.43%             |  |  |  | No            |                  1 | On Loan: —       |
| Amylyx Pharmaceuticals Inc       | Amylyx Pharmaceuticals Inc                                                  | CUSIP: 03237H101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    188646 | NS      | $6970469.70   | 3.40%             |  |  |  | No            |                  1 | On Loan: No      |
| State Street Global Advisors     | State Street Navigator Securities Lending Government Money Market Portfolio | CUSIP: 857492706<br>LEI: 5493008BJIBKQ5KTIF74 | Long             | STIV             | RF                | US        |  18307468 | NS      | $18307468.25  | 8.93%             |  |  |  | No            |                  1 | On Loan: No      |
| DICE Therapeutics Inc            | DICE Therapeutics Inc                                                       | CUSIP: 23345J104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     87166 | NS      | $2719579.20   | 1.33%             |  |  |  | No            |                  1 | On Loan: No      |
| Organon & Co                     | Organon & Co                                                                | CUSIP: 68622V106<br>LEI: 549300AMCKY57OK2CO56 | Long             | EC               | CORP              | US        |    328028 | NS      | $9161822.04   | 4.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Atea Pharmaceuticals Inc         | Atea Pharmaceuticals Inc                                                    | CUSIP: 04683R106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    134161 | NS      | $645314.41    | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Innoviva Inc                     | Innoviva Inc                                                                | CUSIP: 45781M101<br>LEI: 549300ACOX4QTBES6535 | Long             | EC               | CORP              | US        |    121937 | NS      | $1615665.25   | 0.79%             |  |  |  | No            |                  1 | On Loan: No      |
| Pfizer Inc                       | Pfizer Inc                                                                  | CUSIP: 717081103<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | EC               | CORP              | US        |    171561 | NS      | $8790785.64   | 4.29%             |  |  |  | No            |                  1 | On Loan: No      |
| Jazz Pharmaceuticals PLC         | Jazz Pharmaceuticals PLC                                                    | CUSIP: 000000000<br>LEI: 635400GAUMJCLEZRRV50 | Long             | EC               | CORP              | IE        |     58396 | NS      | $9303066.76   | 4.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Ventyx Biosciences Inc           | Ventyx Biosciences Inc                                                      | CUSIP: 92332V107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     99278 | NS      | $3255325.62   | 1.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Harmony Biosciences Holdings Inc | Harmony Biosciences Holdings Inc                                            | CUSIP: 413197104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     74061 | NS      | $4080761.10   | 1.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Arvinas Inc                      | Arvinas Inc                                                                 | CUSIP: 04335A105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    101773 | NS      | $3481654.33   | 1.70%             |  |  |  | No            |                  1 | On Loan: —       |
| Elanco Animal Health Inc         | Elanco Animal Health Inc                                                    | CUSIP: 28414H103<br>LEI: 549300SHPNDCE059M934 | Long             | EC               | CORP              | US        |    700324 | NS      | $8557959.28   | 4.18%             |  |  |  | No            |                  1 | On Loan: No      |
| Merck & Co Inc                   | Merck & Co Inc                                                              | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |     81570 | NS      | $9050191.50   | 4.42%             |  |  |  | No            |                  1 | On Loan: No      |
| SIGA Technologies Inc            | SIGA Technologies Inc                                                       | CUSIP: 826917106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    394155 | NS      | $2900980.80   | 1.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co                   | Eli Lilly & Co                                                              | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |     24580 | NS      | $8992347.20   | 4.39%             |  |  |  | No            |                  1 | On Loan: No      |
| Royalty Pharma PLC               | Royalty Pharma PLC                                                          | CUSIP: 000000000<br>LEI: 549300FGFN7VOK8BZR03 | Long             | EC               | CORP              | GB        |    212529 | NS      | $8399146.08   | 4.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Catalent Inc                     | Catalent Inc                                                                | CUSIP: 148806102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    198594 | NS      | $8938715.94   | 4.36%             |  |  |  | No            |                  1 | On Loan: No      |
| Corcept Therapeutics Inc         | Corcept Therapeutics Inc                                                    | CUSIP: 218352102<br>LEI: 529900EO9LUTFMZ7FF90 | Long             | EC               | CORP              | US        |    143108 | NS      | $2906523.48   | 1.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Bristol-Myers Squibb Co          | Bristol-Myers Squibb Co                                                     | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |    112560 | NS      | $8098692.00   | 3.95%             |  |  |  | No            |                  1 | On Loan: No      |
| State Street Global Advisors     | State Street Institutional Liquid Reserves Fund                             | CUSIP: 85749P101<br>LEI: 5493000HFJPORCLSV250 | Long             | STIV             | RF                | US        |    190904 | NS      | $190941.93    | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2023-01-23

**Name of Applicant:** SPDR SERIES TRUST

**Signature:** Arthur Jensen

**Name of Signer:** Arthur Jensen

**Title:** Deputy Treasurer